Cardiff Oncology Stock Probability of Future Stock Price Finishing Over 19.67
| CRDF Stock | USD 2.66 0.05 1.92% |
Cardiff |
Cardiff Oncology Target Price Odds to finish over 19.67
The tendency of Cardiff Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over $ 19.67 or more in 90 days |
| 2.66 | 90 days | 19.67 | close to zero percent |
Based on a normal probability distribution, the odds of Cardiff Oncology to move over $ 19.67 or more in 90 days from now is close to zero percent (This Cardiff Oncology probability density function shows the probability of Cardiff Stock to fall within a particular range of prices over 90 days) . Probability of Cardiff Oncology price to stay between its current price of $ 2.66 and $ 19.67 at the end of the 90-day period is about 56.11 .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.24 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Cardiff Oncology will likely underperform. Additionally Cardiff Oncology has an alpha of 0.236, implying that it can generate a 0.24 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Cardiff Oncology Price Density |
| Price |
Predictive Modules for Cardiff Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cardiff Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cardiff Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Cardiff Oncology Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cardiff Oncology is not an exception. The market had few large corrections towards the Cardiff Oncology's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cardiff Oncology, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cardiff Oncology within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.24 | |
β | Beta against Dow Jones | 1.24 | |
σ | Overall volatility | 0.39 | |
Ir | Information ratio | 0.05 |
Cardiff Oncology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cardiff Oncology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cardiff Oncology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cardiff Oncology had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 488 K. Net Loss for the year was (41.44 M) with loss before overhead, payroll, taxes, and interest of (26.72 M). | |
| Cardiff Oncology currently holds about 122.01 M in cash with (30.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardiff Oncology has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS ... |
Cardiff Oncology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cardiff Stock often depends not only on the future outlook of the current and potential Cardiff Oncology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cardiff Oncology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 44.7 M | |
| Cash And Short Term Investments | 74.8 M |
Cardiff Oncology Technical Analysis
Cardiff Oncology's future price can be derived by breaking down and analyzing its technical indicators over time. Cardiff Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cardiff Oncology. In general, you should focus on analyzing Cardiff Stock price patterns and their correlations with different microeconomic environments and drivers.
Cardiff Oncology Predictive Forecast Models
Cardiff Oncology's time-series forecasting models is one of many Cardiff Oncology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Cardiff Oncology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Cardiff Oncology
Checking the ongoing alerts about Cardiff Oncology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Cardiff Oncology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Cardiff Oncology had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 488 K. Net Loss for the year was (41.44 M) with loss before overhead, payroll, taxes, and interest of (26.72 M). | |
| Cardiff Oncology currently holds about 122.01 M in cash with (30.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.82, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cardiff Oncology has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Cardiff Oncology Announces New Patent with Claims for the Use of Onvansertib in Treating KRAS ... |
Check out Cardiff Oncology Backtesting, Cardiff Oncology Valuation, Cardiff Oncology Correlation, Cardiff Oncology Hype Analysis, Cardiff Oncology Volatility, Cardiff Oncology History as well as Cardiff Oncology Performance. For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardiff Oncology. If investors know Cardiff will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardiff Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.95) | Revenue Per Share 0.015 | Quarterly Revenue Growth 0.17 | Return On Assets (0.38) | Return On Equity (0.68) |
The market value of Cardiff Oncology is measured differently than its book value, which is the value of Cardiff that is recorded on the company's balance sheet. Investors also form their own opinion of Cardiff Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cardiff Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardiff Oncology's market value can be influenced by many factors that don't directly affect Cardiff Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardiff Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiff Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiff Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.